Serratus Posterior Superior Intercostal Plane Block in Minimally Invasive Cardiac Surgery
Condition(s) studied
Investigational drug(s) / intervention(s)
Serratus Posterior Superior Intercostal Plane Block With Bupivacaine: Participants in this group will receive an ultrasound-guided serratus posterior superior intercostal plane (SPSIP) block prior to surgery using 30 mL of 0.25% bupivacaine, in addition to standard general anesthesia and multimodal analgesia.
Serratus Posterior Superior Intercostal Plane Block With Saline: Participants in this group will receive an ultrasound-guided placebo block using 30 mL of normal saline under identical conditions, in addition to standard general anesthesia and multimodal analgesia.
Study summary
This randomized, double-blind, placebo-controlled study aims to evaluate the effect of the serratus posterior superior intercostal plane (SPSIP) block on postoperative pain and opioid consumption in patients undergoing minimally invasive cardiac valve surgery via mini-thoracotomy.
Eligibility
Primary outcome measure(s)
- 24-hour cumulative opioid consumption — 24 hours after surgery
Total opioid consumption within the first 24 hours after surgery, expressed as intravenous morphine milligram equivalents (IV-MME).
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Fatma Acil | Diyarbakır | Outside of the US | Recruiting |
More Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital trials in Turkey
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07588230 on ClinicalTrials.gov ↗ ← All trials in Turkey